Skip to main content
. 2022 Jan 20;14(2):845–868. doi: 10.18632/aging.203845

Table 2. Differentially expressed genes in the risk score calculation formula.

Gene Protein name Gene bank accession number Function
WNT7B [56, 57] Wnt7b protein AY400071 WNT7B is involved in tumor growth promotion, immunosuppression, angiogenesis, and cancer cell dissemination.
LEF1 [58] Lymphoid enhancer binding factor 1 AY129650 LEF1 regulates glutathione metabolism, increases chemotherapy resistance, and promotes breast cancer brain metastasis.
BCL2A1 [59, 60] BCL2 related protein A1 DQ081729 BCL2A1 represses hypoxia-induced cell death and mitochondria-mediated apoptosis and promotes tumor growth and metastasis.
ULBP2 [61, 62] UL16 binding protein 2 AY358665 ULBP2 increases NK cell cytotoxicity resistance and promotes cervical cancer proliferation, invasion, and migration.
GABRQ [63, 64] Gamma-aminobutyric acid type A receptor subunit theta KJ899212 GABRQ promotes hepatocellular cancer cell proliferation.
FXYD3 [65] FXYD domain containing ion transport regulator 3 KJ891826 FXYD3 promotes breast cancer cell proliferation.
SCG2 [66] Secretogranin II KJ897788 SCG2 enhances endothelial angiogenesis.
FOXJ1 [6770] Forkhead box J1 KJ891181 FOXJ1 promotes bladder cancer, prostate cancer, hepatocellular cancer, and gastric cancer growth, and metastasis.
TP63 [71] Tumor protein p63 KR711025 TP63 increases expression of epidermal growth factor receptor in breast cancer and increases the response of breast cancer to cisplatin.
RYR1 [72] Ryanodine receptor 1 AH006668 RYR1 plays a vital role as a calcium channel in excitation-contraction coupling in muscle.
FEZ1 [7376] Fasciculation and elongation protein zeta 1 AF123653 FEZ1 suppresses prostate, esophageal, gastric, bladder, and breast cancer progression, and mediates promoter methylation-mediated transcriptional downregulation and mitosis inhibition.
NRG1 [77] Neuregulin 1 CR450288 Heregulin isoforms encoded by NRG1 promote tumor growth and induce metastasis.
NFE2 [78] Nuclear factor, erythroid 2 CR450284 NFE2 promotes breast cancer cell growth in the bone microenvironment, which leads to bone metastasis; enhances expression of Wnt-related molecules.
HOXC13 [79] Homeobox C13 AF263466 HOXC13 facilitates cervical cancer cell proliferation, migration, invasion and glycolysis through the β-catenin/c-Myc signaling pathway.
MMP25 [80] Matrix metallopeptidase 25 HF584190 High expression of MMP25 in head and neck cancer is associated with a worse prognosis; MMP25 is related to apoptosis, the KRS signaling pathway, the PI3K/AKT/mTOR signaling pathway, and the JAK/STAT signaling pathway.
DTX1 [81, 82] Deltex E3 ubiquitin ligase 1 KT584324 DTX1 is a regulator of the Notch signaling pathway and acts as an E3 ubiquitin ligase that can repress Notch gene expression and inhibit early-stage non-small cell lung carcinoma growth.